{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:34Z","timestamp":1740107194266,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH047","ZR2021QH268"],"award-info":[{"award-number":["ZR2020QH047","ZR2021QH268"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200629"],"award-info":[{"award-number":["32200629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00405-023-08186-4","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T11:02:44Z","timestamp":1692615764000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel frameshift mutation of the endoglin(ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family"],"prefix":"10.1007","volume":"281","author":[{"given":"Peng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuda","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7554-4094","authenticated-orcid":false,"given":"Huaiqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"8186_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","volume":"245","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31\u201339","journal-title":"J Intern Med"},{"key":"8186_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/cge.12693","volume":"90","author":"AM Jelsig","year":"2016","unstructured":"Jelsig AM, Torring PM, Kjeldsen AD et al (2016) JP-HHT phenotype in Danish patients with SMAD4 mutations. Clin Genet 90:55\u201362","journal-title":"Clin Genet"},{"key":"8186_CR3","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","volume":"103","author":"A Kritharis","year":"2018","unstructured":"Kritharis A, Al-Samkari H, Kuter DJ (2018) Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective. Haematologica 103:1433\u20131443","journal-title":"Haematologica"},{"key":"8186_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2015.00001","volume":"6","author":"J McDonald","year":"2015","unstructured":"McDonald J, Wooderchak-Donahue W, VanSant WC, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015) Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6:1","journal-title":"Front Genet"},{"key":"8186_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12890-021-01524-4","volume":"21","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang YB, Liang LJ et al (2021) NAPG mutation in family members with hereditary hemorrhagic telangiectasia in China. BMC Pulm Med 21:197","journal-title":"BMC Pulm Med"},{"key":"8186_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MOH.0000000000000493","volume":"26","author":"A Hata","year":"2019","unstructured":"Hata A, Lagna G (2019) Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia. Curr Opin Hematol 26:161\u2013169","journal-title":"Curr Opin Hematol"},{"key":"8186_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MCP.0000000000000472","volume":"24","author":"S Kroon","year":"2018","unstructured":"Kroon S, Snijder RJ, Faughnan ME, Mager HJ (2018) Systematic screening in hereditary hemorrhagic telangiectasia: a review. Curr Opin Pulm Med 24:260\u2013268","journal-title":"Curr Opin Pulm Med"},{"key":"8186_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1538-7836.2007.02531.x","volume":"5","author":"C Sabb\u00e0","year":"2007","unstructured":"Sabb\u00e0 C, Pasculli G, Lenato GM et al (2007) Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5:1149\u20131157","journal-title":"J Thromb Haemost"},{"key":"8186_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","volume":"93","author":"WL Wooderchak-Donahue","year":"2013","unstructured":"Wooderchak-Donahue WL, McDonald J, O\u2019Fallon B et al (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93:530\u2013537","journal-title":"Am J Hum Genet"},{"key":"8186_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ajmg.a.36936","volume":"167","author":"L Pawlikowska","year":"2015","unstructured":"Pawlikowska L, Nelson J, Guo DE et al (2015) The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Am J Med Genet A 167:1262\u20131267","journal-title":"Am J Med Genet A"},{"key":"8186_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2017.11.013","volume":"93","author":"VN Iyer","year":"2018","unstructured":"Iyer VN, Apala DR, Pannu BS et al (2018) Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding. Mayo Clin Proc 93:155\u2013166","journal-title":"Mayo Clin Proc"},{"key":"8186_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1746-1596-7-9","volume":"7","author":"R Bayrak","year":"2012","unstructured":"Bayrak R, Haltas H, Yenidunya S (2012) The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol 7:9","journal-title":"Diagn Pathol"},{"key":"8186_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cncy.20135","volume":"119","author":"N Fatima","year":"2011","unstructured":"Fatima N, Cohen C, Lawson D, Siddiqui MT (2011) TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol 119:127\u2013133","journal-title":"Cancer Cytopathol"},{"key":"8186_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17:860\u2013871","journal-title":"Eur J Hum Genet"},{"key":"8186_CR15","first-page":"18","volume":"58","author":"DT Liu","year":"2020","unstructured":"Liu DT, Frohne A, Koenighofer M et al (2020) Plasma VEGF - a candidate biomarker for response to treatment with bevacizumab in HHT patients. Rhinology 58:18\u201324","journal-title":"Rhinology"},{"key":"8186_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12881-017-0380-0","volume":"18","author":"V Albinana","year":"2017","unstructured":"Albinana V, Zafra MP, Colau J et al (2017) Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1. BMC Med Genet 18:20","journal-title":"BMC Med Genet"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-08186-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-023-08186-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-08186-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T12:05:25Z","timestamp":1704283525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-023-08186-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["8186"],"URL":"https:\/\/doi.org\/10.1007\/s00405-023-08186-4","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"29 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of the Linyi People\u2019s Hospital approved the research protocol, and written informed consent was obtained from every participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}]}}